Sagespring Wealth Partners LLC Acquires 556 Shares of Danaher Corporation (NYSE:DHR)

Sagespring Wealth Partners LLC increased its holdings in Danaher Corporation (NYSE:DHR) by 14.0% in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 4,535 shares of the conglomerate’s stock after acquiring an additional 556 shares during the quarter. Sagespring Wealth Partners LLC’s holdings in Danaher were worth $930,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other large investors also recently bought and sold shares of the business. LaFleur & Godfrey LLC lifted its position in Danaher by 1.5% in the 4th quarter. LaFleur & Godfrey LLC now owns 29,855 shares of the conglomerate’s stock valued at $6,853,000 after acquiring an additional 440 shares in the last quarter. Union Bancaire Privee UBP SA bought a new position in shares of Danaher during the fourth quarter valued at $74,551,000. Bank Pictet & Cie Europe AG boosted its position in shares of Danaher by 22.8% during the fourth quarter. Bank Pictet & Cie Europe AG now owns 192,731 shares of the conglomerate’s stock valued at $44,241,000 after buying an additional 35,730 shares during the last quarter. Congress Asset Management Co. boosted its holdings in shares of Danaher by 629.0% during the 4th quarter. Congress Asset Management Co. now owns 7,516 shares of the conglomerate’s stock valued at $1,725,000 after acquiring an additional 6,485 shares during the last quarter. Finally, Principal Securities Inc. grew its stake in shares of Danaher by 4.7% in the fourth quarter. Principal Securities Inc. now owns 14,979 shares of the conglomerate’s stock worth $3,438,000 after acquiring an additional 668 shares during the period. 79.05% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Several equities research analysts recently issued reports on DHR shares. Stifel Nicolaus upgraded shares of Danaher from a “hold” rating to a “buy” rating and set a $260.00 target price on the stock in a report on Friday, March 14th. HSBC cut their price objective on Danaher from $270.00 to $240.00 in a report on Friday, April 25th. Barclays increased their target price on Danaher from $205.00 to $215.00 and gave the company an “overweight” rating in a report on Tuesday, April 22nd. Wall Street Zen downgraded Danaher from a “buy” rating to a “hold” rating in a research note on Monday, June 9th. Finally, Wells Fargo & Company reduced their price target on shares of Danaher from $240.00 to $210.00 and set an “equal weight” rating for the company in a research report on Wednesday, April 23rd. Five investment analysts have rated the stock with a hold rating and sixteen have issued a buy rating to the company’s stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average target price of $248.17.

Insider Transactions at Danaher

In related news, EVP Christopher Paul Riley sold 15,805 shares of the business’s stock in a transaction on Wednesday, April 30th. The shares were sold at an average price of $198.00, for a total value of $3,129,390.00. Following the sale, the executive vice president now owns 15,179 shares in the company, valued at approximately $3,005,442. The trade was a 51.01% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, Chairman Steven M. Rales sold 1,250,000 shares of Danaher stock in a transaction on Monday, May 12th. The stock was sold at an average price of $196.74, for a total transaction of $245,925,000.00. Following the completion of the transaction, the chairman now directly owns 3,105,808 shares of the company’s stock, valued at $611,036,665.92. The trade was a 28.70% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 11.20% of the company’s stock.

Danaher Price Performance

NYSE:DHR opened at $195.81 on Wednesday. The business’s 50-day simple moving average is $193.42 and its two-hundred day simple moving average is $210.43. Danaher Corporation has a 52 week low of $171.00 and a 52 week high of $281.70. The stock has a market cap of $140.13 billion, a PE ratio of 38.02, a P/E/G ratio of 2.82 and a beta of 0.77. The company has a quick ratio of 1.05, a current ratio of 1.43 and a debt-to-equity ratio of 0.31.

Danaher (NYSE:DHR) last posted its quarterly earnings results on Tuesday, April 22nd. The conglomerate reported $1.88 EPS for the quarter, topping analysts’ consensus estimates of $1.62 by $0.26. Danaher had a return on equity of 10.80% and a net margin of 15.81%. The company had revenue of $5.74 billion for the quarter, compared to analysts’ expectations of $5.58 billion. As a group, analysts forecast that Danaher Corporation will post 7.63 EPS for the current fiscal year.

Danaher Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, July 25th. Stockholders of record on Friday, June 27th will be given a dividend of $0.32 per share. This represents a $1.28 dividend on an annualized basis and a dividend yield of 0.65%. Danaher’s payout ratio is 24.85%.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.